← Open Payments lookup

ALLISON MOORE: Open Payments

NPI 1770643843 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,283 in 61 payments from 9 companies in 2025. Trend: 2023 $1,421 · 2024 $1,124 · 2025 $1,283

Food & beverage: $1,283
CompanyPaymentsAmount
Gilead Sciences, Inc.24$414
ABBVIE INC.12$277
Madrigal Pharmaceuticals6$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$138
Ipsen Biopharmaceuticals, Inc4$101
Intercept Pharmaceuticals, Inc.4$98
ORPHALAN INC2$53
Intra-Sana Laboratories1$25
Eton Pharmaceuticals, Inc.1$23

Products named: MAVYRET, REZDIFFRA, XIFAXAN, IQIRVO, OCALIVA, CUVRIOR, RELTONE 200 MG, ALKINDI.

Industry payments across TX — which companies pay providers there.